Orzan Anca, Novac Carmen, Mihu Mihaiela, Tirgoviste Constantin Ionescu, Balgradean Mihaela
"Marie Curie" Emergency Children's Hospital, Bucharest, Romania ; "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
"Marie Curie" Emergency Children's Hospital, Bucharest, Romania.
Maedica (Bucur). 2016 Dec;11(4):308-312.
Autoimmune thyroid disease and type 1 diabetes (T1DM) are two autoimmune diseases frequently associated, especially in pediatric population. Aims: we wanted to determine and ilustrate the relationship between type 1 diabetes and autoimmune thyroiditis and also the factors than can influence it, like gender, age, diabetes duration. Glycemic control was also evaluated for all the patients.
There were studied 256 patients, children and adolescents with T1DM (male/ female: 145/115; 55%/45%). Anti-TPO antibodies were detected using the electrohemiluminescence method and glycosylated haemoglobin A1c (HbA1c) was measured through a imunoturbidimetric method. The patients were clinically examined, including thyroid gland palpation, blood pressure measurement and assessment of their pubertal status and growth.
Age distribution at the time of T1DM diagnosis: most of them, 26% were diagnosed between 6 and 9 years, 23% between 1-3 years, 21% between 3-6 years, 19% between 9-12 years, 9% between 12-15 years, and very few of them (2%) were diagnosed between 15 and 18 years. Among these patients, 47/256 (18.3 %) were positive for thyroid antibodies (anti - TPO). In 2 of 47 patients tests for anti TPO antibodies were positive at the time of T1DM diagnosis. Tests for anti - TPO antibodies became positive with an average of 5.09±3.84 ( range 0-13) years after the diagnosis of T1DM. At the time that anti - thyroid antibodies were first seen to be positive all patients were euthyroid with a mean age of 11.3 years (range 4 -16) and a mean diabetes duration of 5.21±3.57 (range 0-9 years). After 5±3.3 years (range 0- 9 years) a progression towards subclinical hypothyroidism due to Hashimoto thyroiditis was observed in 41 from 47 patients (87.2%), while no patient developed clinical hypoythyroidism. It was observed an 9.2 % ±1.5% mean value of HbA1c in patients with thyroiditis comparative with 7.9 % ± 0.7 % mean HbA1c value in those without thyroiditis.
Thyroid autoimmunity is frequently present among T1DM patients, can be associated with increased age, female gender, long diabetes duration, and can inbalance the glycemic control of T1DM patients.
自身免疫性甲状腺疾病和1型糖尿病(T1DM)是两种常伴发的自身免疫性疾病,在儿童群体中尤为常见。目的:我们想要确定并阐明1型糖尿病与自身免疫性甲状腺炎之间的关系,以及可能影响这种关系的因素,如性别、年龄、糖尿病病程。还对所有患者的血糖控制情况进行了评估。
研究了256例T1DM患儿及青少年(男/女:145/115;55%/45%)。采用电化学发光法检测抗甲状腺过氧化物酶(Anti-TPO)抗体,通过免疫比浊法测定糖化血红蛋白A1c(HbA1c)。对患者进行临床检查,包括甲状腺触诊、血压测量以及青春期状态和生长情况评估。
T1DM诊断时的年龄分布:大多数患者(26%)在6至9岁被诊断,23%在1至3岁,21%在3至6岁,19%在9至12岁,9%在12至15岁,只有极少数患者(2%)在15至18岁被诊断。在这些患者中,47/256(18.3%)甲状腺抗体(抗TPO)呈阳性。47例患者中有2例在T1DM诊断时抗TPO抗体检测呈阳性。抗TPO抗体检测在T1DM诊断后平均5.09±3.84年(范围0 - 13年)转为阳性。首次发现抗甲状腺抗体呈阳性时,所有患者甲状腺功能正常,平均年龄为11.3岁(范围4 - 16岁),平均糖尿病病程为5.21±3.57年(范围0 - 9年)。5±3.3年(范围0 - 9年)后,47例患者中有41例(87.2%)因桥本甲状腺炎进展为亚临床甲状腺功能减退,而无患者发展为临床甲状腺功能减退。甲状腺炎患者的HbA1c平均水平为9.2%±1.5%,无甲状腺炎患者的HbA1c平均水平为7.9%±0.7%。
T1DM患者中甲状腺自身免疫现象常见,可能与年龄增长、女性性别、糖尿病病程长有关,并且会影响T1DM患者的血糖控制。